Hlavní stranaMezinárodní spoluprácePeptide for cancer control linked to IL13Ralpha2...

Peptide for cancer control linked to IL13Ralpha2 overexpression

Datum: 30.7.2018 

Summary:

A Spanish Research Public Organization has developed a peptide capable of inhibiting the signaling of Interleukin 13 mediated by interleukin 13 receptor The peptide alone or within a nanoparticle or virus-like particles can be used in a pharmaceutical composition for the treatment of pathologies in which it is overexpressed: control of metastasis of colon cancer and other tumors (i.e glioblastoma), asthma, atopic dermatitis or fibrosis. Industrial partners are being sought for licence agreement.

Reference: TOES20180117001

Country: Spain

Submitted: 30. 7. 2018

View Partnering Opportunity

 

Keywords

Technology: Cytology, Cancerology, Oncology; Medical Research, Pharmaceutical Products / Drugs

Market: Pulmonary medicine, Oncology

NACE: Research and experimental development on biotechnology

 


Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.

 


 

OPPI, MPO, EU
Czech Bio

CEBIO a I. etapa JVTP

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

Provozovatel

Jihočeská agentura pro podporu inovačního podnikání o.p.s.

Články na přání


[načítám anketu]

LinkedIn